Clinical trials recruiting for Non-metastatic Castration-resistant Prostate Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Darolutamide (Nubeqa, BAY1841788) | 2 |
| ADT | 1 |
| Darolutamide | 1 |
Self-screener
Recruiting trials
- A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
- An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
- An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
- PROCARE - PROstate Cancer Real World Evidence Registry
Related conditions
Trials recruiting for Non-metastatic Castration-resistant Prostate Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Non-metastatic Castration-resistant Prostate Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.